OBJECTIVE: Several gastrointestinal peptides are now recognized to have target functions beyond the intestinal wall, including effects on adipocytes. Secretin (SEC), one of the first identified, has not been evaluated in this context. METHODS: Using cultured 3T3-L1 preadipocytes, adipocytes and primary rat adipocytes we evaluated the effect of SEC on cell proliferation, mitochondrial activity, differentiation, triglyceride (TG) synthesis, lipolysis as well expression of the SEC receptor (SCTR) in rodent and human adipose tissues. RESULTS: In preadipocytes, SEC significantly increased mitochondrial activity (115%; Po0.01), thymidine incorporation (149.7%; Po0.05) and C/EBPb expression (123.4%; Po0.05). During standard differentiation, SCTR mRNA increased up to a maximum of ninefold (Po0.001). In human adipose tissue, SCTR correlated with body mass index and plasma insulin, and SCTR mRNA expression was also detected in rat adipose tissues. SEC supplementation during differentiation enhanced TG accumulation ( þ 138%; Po0.01). In mature adipocytes, SEC increased fatty acid (FA) uptake (186%; Po0.01), adiponectin and monocyte chemotactic protein-1 secretion ( þ 142% and þ 149%, respectively; Po0.05) and mRNA expression of PPARg ( þ 206%; Po0.01), FABP4 ( þ 164%; Po0.001), DGAT-1 ( þ 144%; Po0.01), adiponectin ( þ 138%; Po0.001) and CD36 ( þ 149%; Po0.05). In primary rat adipocytes, SEC also increased FA uptake (137%; Po0.05). Pretreatment with a SEC antagonist impaired SEC-induced FA uptake and cAMP accumulation. SEC treatment simultaneously stimulated lipolysis measured as glycerol release in 3T3-L1 adipocytes and rat adipose tissue. CONCLUSION: The present results suggest that SEC is a potent modulator of adipocyte functions, demonstrating overall a role in enhanced substrate cycling.
INTRODUCTION
In response to the dramatic increase in the incidence of obesityrelated dysfunctions over the last 30 years, there is a growing interest regarding the mechanisms governing the regulation of adipocyte functions. Several cellular mechanisms (adipocyte differentiation and proliferation) involved in the regulation of adipocyte hyperplasia and hypertrophy have already been elucidated, 1 however, the signals triggering these changes remain largely uncharacterized. Insulin can positively influence the differentiation of preadipocytes into fully functional mature adipocytes. 2 In addition, excessive dietary intakes have effects on adipocyte functions. 3 In 2000, Tschö p et al. 4 have described that the gastrointestinal (GI) orexigenic peptide ghrelin could influence adipogenesis in rodents. Additional GI peptides such as glucosedependent insulinotropic polypeptide, desacyl ghrelin, substance P and neurotensin were also shown to influence preadipocyte differentiation and/or proliferation. [5] [6] [7] [8] [9] These elements suggest the relevance of considering GI peptides with known digestive and absorptive effects as potential mediators of preadipocytes and differentiating and mature adipocyte functions.
Although it was discovered in 1902 by Bayliss and Starling, secretin (SEC) is a 27-amino-acid peptide hormone 10 for which the metabolic effects beyond the GI system have been overlooked in the past. 11 Following food intake, SEC is mainly released by duodenal S cells from the crypts of Lieberkü hn in response to intestinal acidification and consequently stimulates the release of bicarbonate, water and electrolytes from the pancreas. 12 In addition, plasma SEC levels increase both before and after gastroplasty following the intake of a standard fluid meal in obese patients. 13 SEC was shown to be preferentially secreted in response to the intestinal absorption of long and medium fatty acid (FA) carbon chains 14 and it stimulates both bile and pancreatic secretion. In addition, SEC may be involved in stimulation of insulin secretion, cardiac output, renal functions and bronchorelaxation, whereas it also reduces food intake and gastric motility. 15 At the cellular level, the effects of SEC are likely to be tissue dependent. SEC has no effect on proliferation or metabolism in pancreatic MIA PaCa 2 cells 16 inhibits differentiation in villus cells, 17 but stimulates mitosis in isolated primary cholangiocytes, whereas attenuating proliferation in tumoral cholangiocytes. 18 SEC induces cAMP accumulation in cultured bile duct cells 19 and stimulates IL-2 and IFN-g secretion from human mononuclear cells. 20 SEC activates the SEC receptor (SCTR) but could also potentially interact with other type II G-protein coupled receptors, such as vasointestinal peptide receptors, VAPC1 or VPAC2, and pituitary adenylate cyclase-activating peptide receptor. 21, 22 SCTR mRNA expression was observed in non-obese adipose tissue 23 with increases in omental adipose tissue of obese individuals. 24 In normal and diabetic rodent models, the binding of SEC to 1 adipocytes and the potential mechanisms through which effects could be mediated are still debated. 25, 26 Contrasting results have been published regarding the potential effect of SEC on glycerol release in primary adipocytes. 27, 28 Although studies have investigated the influence of SEC on several metabolic activities, there is little information regarding the potential effects of SEC on adipocyte functions. Therefore, the present study was designed to investigate the effect of SEC on lipid metabolism (FA and glucose uptake, triglyceride (TG) synthesis and lipolysis) as well as gene expression in differentiating and mature adipocytes. Finally, the expression of the SCTR and other markers of proliferation and/or adipocyte differentiation were also investigated in a model of 3T3-L1 cells, and in rodent and human adipose tissues.
MATERIALS AND METHODS Reagents
Insulin-like growth factor 1 and insulin were purchased from Sigma-Aldrich (Oakville, Ontario, Canada). 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) was obtained from Promega Corporation (Madison, WI, USA). DMEM/F12, phosphate buffered saline (PBS), bovine calf serum and fetal bovine serum (FBS) were supplied by GIBCO (Burlington, Ontario, Canada). Isobutylmethylxanthine, dexamethasone, penicillin-streptomycin and trypsin were from Life Technologies (Carlsbad, CA, USA), 2-deoxy-D [1- 3 H]glucose and 3 H-thymidine were purchased from GE Healthcare (Montreal, Qué bec, Canada). Porcine SEC 5-27 (S5-27) and cAMP kit were purchased from AnaSpec (San Joe, CA, USA) and R&D systems (Minneapolis, MN, USA), respectively. Beta-cylodextrin was from Supelco (Bellefonte, PA, USA) and SEC (human sequence) was generously provided by Peptidec Technologies Ltd (Montré al, Qué bec, Canada). Peptide purity (495%) and identity were confirmed by analytical RP-HPLC using a C 18 3 mm column and by LC-MS. Concentrated peptide solutions (1 mg ml À 1 ) in PBS were aliquoted and stored at À 80 1C. SEC concentrations used had previously been shown to elicit a response in vitro.
Cell culture of 3T3-L1 preadipocytes and standard differentiation into mature adipocytes 3T3-L1 preadipocytes (ATCC, Manassas, VA, USA) were routinely cultured in DMEM/F12 supplemented with 10% bovine calf serum medium (37 o C, 5% CO 2 ) and were subdivided at o70% confluence. Preadipocytes were differentiated to adipocytes as described previously. 29 
Effect of SEC on preadipocyte functions
Mitochondrial activity. Mitochondrial activity was evaluated using the Cell Titer 96 Aqueous One Solution (Promega Corporation) as described by the manufacturer. The MTS assay is a colorimetric assay containing a tetrazolium compound which, when reduced, produces formazan, an end-product with colorimetric properties. The compound is reduced because of the mitochondrial activity in the cell. As previously reported in the literature, the assay can be used to evaluate metabolic activity, proliferation, cytotoxicity or viability.
Preadipocyte proliferation. 3T3-L1 were seeded (1 Â 10 4 cells per well) on a 48-well plate then treated with SEC and thymidine incorporation into these cells was measured as previously described. 30 Effect of SEC on 3T3-L1 adipocyte differentiation
The effect of SEC on 3T3-L1 preadipocyte differentiation was evaluated using a modification of the procedure described above. Two-day postconfluent preadipocytes were treated with the standard differentiation medium but supplemented with SEC (at the indicated concentrations) for 3 days. The medium was then changed to DMEM/F12, 10% FBS with 1.721 mM insulin supplemented with SEC for a further 3 days. Finally, the medium was changed to DMEM/F12, 10% FBS with/without SEC supplements for 3 days. On day 9, 3T3-L1 mature adipocytes were processed for lipid extraction with 200 ml heptane-isopropanol (3:2) overnight at 4 o C and rinsed with an additional 500 ml of the same solvent. Lipid extracts were evaporated to dryness in a centrifuge-evaporator (Canberra-Packard, Mississauga, Ontario, Canada) and re-dissolved in 50 ml heptane-isopropanol (3:2). TG mass was measured using an enzymatic colorimetric assay (Roche Diagnostics, Indianapolis, IN, USA), absorbance was then measured at 490 nm and normalized per mg of cell protein.
Effect of SEC on mature adipocyte functions 3T3-L1 adipocytes were prepared as described in the standard differentiation protocol above.
FA uptake. Mature adipocytes were preincubated for 2 h in serum-free DMEM/F12 and then treated with hormones (at the concentrations indicated) for 1 h (200 ml, in serum-free DMEM/F12). FA uptake and incorporation were evaluated in the constant presence of the hormones as previously described. In some experiments cells were pre-treated for 30 min with the SEC inhibitor (5-27) at 5 mM, or caveolae disruptor, b-cyclodextrin, at 50 mM before the addition of SEC.
Glucose uptake in 3T3-L1 adipocytes. Mature 3T3-L1 adipocytes were preincubated for 2 h in serum-free DMEM/F12, then treated with hormones at the indicated concentrations for 1 h (200 ml in serum-free DMEM/F12). Glucose uptake (measured as 2-deoxy-glucose uptake) was performed as previously described.
Lipolysis. Following standard differentiation, mature 3T3-L1 adipocytes were preincubated in serum-free medium for 2 h and then treated with SEC and isoproterenol (at the indicated concentrations). Media were collected after 3, 6 and 24 h, glycerol and non-esterified fatty acid (NEFA) concentrations were measured using colorimetric enzyme assays (Wako, Osaka, Japan, and Roche Diagnostics, respectively). Glycerol and NEFA concentrations were normalized per nmol of cell TG mass.
Measurement of adipokine release. Adipocytes were incubated for 24 h with the indicated hormones and the cell culture medium was collected. Adiponectin, monocyte chemotactic protein-1 (MCP-1) and keratinocytederived chemokine levels were assessed using a mouse Duoset enzymelinked immunosorbent assay (ELISA) (R&D Systems). Acylation-stimulating protein and complement C3 levels were evaluated with a mouse ELISA (BD Biosciences, San Diego, CA, USA) and mouse complement C3 ELISA (Kamiya Biomedical Company, Seattle, WA, USA), respectively.
Effect of SEC on intracellular cyclic AMP production. Cells were treated with 0.1 nM SEC overnight. Where indicated, cells were pre-treated for 30 min with SEC fragment 5-27 (S5-27; recognized as an inhibitor of SEC) before the addition of SEC. The following day, medium was removed, cells washed twice with cold PBS then scraped and lysed with a cell lysis buffer. The mixture was dissociated and then centrifuged at 600 g for 10 min. The supernatant was retained, and cAMP levels were determined with a competitive ELISA cAMP kit as described by the manufacturer 0 s protocol (R&D Systems).
RT-PCR assays in 3T3-L1 cells and primary rat adipocytes. The following cells were collected for mRNA evaluation of gene expression: (i) 3T3-L1 preadipocytes (day 0) treated with 0.1 nM SEC for 24 h, (ii) adipocytes differentiating with standard (PBS or 0.1 nM SEC) protocol collected at various times (3, 6 and 9 days) and (iii) mature adipocytes stimulated with 0.1 nM SEC for 24 h and (iv) primary rat adipocytes isolated as described below. RNA was extracted from 3T3-L1 cells using a RNeasy Mini Kit and RNase-Free DNase Set treatment according to the manufacturer's specifications (Qiagen, Mississauga, Ontario, Canada) and RNA from primary adipocytes (rats) was isolated using RNeasy lipid tissue Mini kit (Qiagen). Total RNA samples of 1 mg were converted to cDNA with random primers in a total volume of 10 ml. Prevention of genomic DNA contamination was achieved by using the RT 2 First Strand Kit (SABiosciences, Frederick, MD, USA). Real-time qRT-PCR array analyses were performed in 96-well plates of a custom mouse RT 2 Profiler PCR array, which contained mouse genomic DNA contamination and reverse transcription control. The array was designed to simultaneously quantify mRNA expression of the indicated and housekeeping genes (SABiosciences). A description of the genes so analyzed is provided in Supplementary Table 1. For assessment of the SEC receptor, RNA was reverse-transcribed using the QuantiTect Reverse Transcription kit (Qiagen). Reactions were used as templates for the PCR assays using a SYBR Green PCR master mix and, specific primers designed against the mouse and rat SEC receptor gene NM_001012322 and NM_031115, respectively, and glyceraldehyde 3-phosphate dehydrogenase mouse and Secretin effects on adipocytes P Miegueu et al rats (NM_008084 and NM_0017008, respectively), the housekeeping gene (Qiagen), as well as Glut4 and IRS-1 (Supplementary Table 1 ) in the realtime thermal cycler CFX96 Real-Time PCR (Bio-Rad Laboratories, Mississauga, Ontario, Canada) instrument as previously described.
Experimental animals and procedures
Animals. Nine-week-old male Sprague-Dawley rats and C57Bl/6 mice were obtained from Charles River Laboratories (Wilmington, MA, USA). Rats were randomly divided into two groups. All experiments were conducted in accordance with the Laval University Guide for the care and use of laboratory animals. The control group (n ¼ 3) was fed standard chow (containing 24.5 g of protein, 51 g of carbohydrate and 4 g of fat/100 g) while the other group (HFD; n ¼ 3) was fed with a high-fat diet (58% lard, 30% fish powder, 10% skim milk and 2% vitamin and mineral mixture; equivalent to 7.5% carbohydrate, 24.5% protein and 60% fat) at libitum. Epididymal fat pads were collected and immediately stored in Krebs 0 s Ringer Buffer pH 7.4.
Primary adipose tissue culture, glucose uptake and lipolysis assay. Epididymal fat depots were minced into small pieces (o10 mg) and cultured in serum-free media in 24-wells plates. Two hours later, explants were treated with and without SEC at 0.1 nM, tissue culture medium was collected after 3 and 24 h and the levels of NEFA and glycerol analyzed as described above. Rat adipose tissues were also finely minced and used for glucose uptake as previously published. 31 Isolation of primary adipocytes, FA uptake and lipolysis. After death, adipose tissues were rinsed immediately in Krebs 0 s Ringer Buffer pH 7.4 and fibrous tissues and blood vessels were carefully dissected and removed. The remaining tissues were minced into small pieces and digested with 0.25% collagenase in 2% BSA for 45 min at 37 1C under continuous shaking. The dispersed tissues were filtered through a nylon mesh sheet (pore size 250 mm), centrifuged and the floating mature adipocytes were collected. Rat primary adipocytes were used to evaluate FA uptake as described above. RNA was also extracted for evaluation of SCTR gene expression.
Human adipose tissues
Human adipose tissues were obtained at time of bariatric surgery as described previously 32, 33 and gene expression data are reported in GEO profiles.
Statistical analysis
Results are presented as mean ± s.e.m. Each experiment was performed in triplicate and repeated at least three times. Comparisons between two treatments were performed by t-tests while one-or two-way analysis of variance combined to Dunnett's post-hoc tests were used to evaluate the difference between more than two treatments. Statistical analyses and graphs were performed using Prism software (Graphpad Software, San Diego, CA, USA). Statistical significance was set as Po0.05, NS indicates not significant.
RESULTS
Effect of SEC on cell proliferation and mitochondrial activity in 3T3-L1 preadipocytes Plasma SEC levels in humans range widely (6-82 pmol l À 1 or 20-250 pg ml À 1 ), based on age, physiological or pathological state, and can increase up to fivefold postprandially. [34] [35] [36] [37] [38] Early publications on SEC in rats indicate circulating plasma levels that are lower than in humans (4.5-21.7 pmol l À 1 ), 39 while very recent publications in mice indicate plasma circulating levels that are considerably higher than in humans (3-5 ng ml
. [40] [41] [42] Concentrations of 0.01 and 0.1 nM (10 and 100 pmol l À 1 ) were chosen for the present experiments. Preadipocytes go through clonal expansion before differentiation. In order to assess the effect of SEC on preadipocyte proliferation, two different set of experiments were carried out. As shown in Figure 1a , although only a marginal effect was observed at 0.01 nM (118 ± 16%; P ¼ NS), treatment with 0.1 nM of SEC significantly increased [ ..Secretin (nM)...
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Retroperitoneal Epididymis Figure 3 . SEC modulates glycerol and NEFA release. 3T3-L1 adipocytes were treated acutely with the indicated SEC concentrations, insulin (50 nM) or isoproterenol (10 mM). The release of glycerol at 3, 6 and 24h were measured in the 3T3-L1 cell culture media (a) and rat adipose tissue media (b). NEFA levels in culture media of SEC treated 3T3-L1 adipocytes (c) or fat depots from rats on chow and high-fat diet were assessed (d). Results are presented as average ± s.e.m. Significant differences were analyzed by t-test (insulin or isoproterenol), or by analysis of variance (SEC) where *Po0.05, **Po0.01 and ***Po0.001.
Secretin effects on adipocytes P Miegueu et al
following the treatment with insulin-like growth factor 1, used as positive control (142 ± 12% vs control; Po0.01). The evaluation of mitochondrial activity through formation of formazan was also evaluated. As presented in Figure 1b , mitochondrial activity of 3T3-L1 preadipocytes was positively modulated by treatment with SEC at 0.1 nM. In addition, as expected, the treatment with insulin at 50 nM also stimulated mitochondrial activity (131±3.9% vs control; Po0.001). In order to further investigate the mechanisms through which SEC could mediate these outcomes; quantitative RT-qPCR analyses on specific genes known to be involved in the regulation of preadipocyte proliferation were analyzed. As presented in Figure 1c , expression of C/EBPb (123 ± 3% vs control; Po0.05) was significantly increased, whereas the one of LYR motif-containing protein (Lyrm; 124 ± 5% vs control; NS) was marginally but not significantly upregulated by treatment with SEC. In contrast, an inhibitory effect of SEC was observed on (myelocytomatosis viral oncogene) Myc and (murine Ki-67 protein) MKi67 mRNA levels ( À 15% and À 25%, respectively, vs control; Po0.05). These elements suggest that SEC could promote mitotic clonal expansion, which is associated with the first steps in 3T3-L1 preadipocyte differentiation.
Effect of SEC on 3T3-L1 preadipocyte differentiation Given that mitotic clonal expansion is an early step in adipogenesis, the long-term (9 days) effect of chronic SEC supplementation on adipocyte differentiation was evaluated. Treatment with SEC at 0.1 nM significantly increased TG content (138±9%; Po0.01; Figure 1d ) over and above the effect of the standard differentiation medium containing insulin, Isobutylmethylxanthine and dexamethasone.
Effect of SEC on mature adipocyte functions FA and glucose uptake. The effect of SEC on FA uptake was investigated in real-time over 2 h in 3T3-L1 adipocytes. As indicated in Figures 2a and B there was a dose-dependent increase in FA uptake in response to treatment with SEC at 0.01 nM (154 ± 1 7%; Po0.05) and 0.1 nM (187 ± 7%; Po0.01). The maximal effect of SEC was comparable to stimulation by insulin (50 nM, 173±11%; Po0.01). In epididymal primary rat adipocytes, SEC (0.1 nM) also increased FA uptake (137 ± 6%, Figure 2c ) vs control; Po0.5), a comparable effect to the one of insulin (140 ± 8% vs control; Po0.05).
In adipocytes, glucose can either be used as a readily available energy source or in de novo biosynthesis of lipids. Therefore, the influence of SEC on glucose uptake was evaluated. In contrast to insulin, treatment with SEC had little effect on glucose transport in mature 3T3-L1 adipocytes (0.1 nM: 137±29% vs control; P ¼ NS, Figure 2d ). However, in rat retroperitoneal and epididymal fat (Figure 2e ), 2-deoxy-( 3 H)D-glucose uptake was stimulated by SEC at 0.1 nM (164±5%; Po0.05), an effect comparable to that of insulin.
Lipolysis. Lipolysis of stored TG in adipocytes results in release of glycerol and NEFA into the culture medium. In 3T3-L1 adipocytes, glycerol release was evaluated over a time course of 3, 6 and 24 h (Figure 3a) . With respect to the control treatment, SEC at 0.1 nM significantly increased glycerol release after 3 h (296%; Po0.001), 6 h (300%; Po0.001) and 24 h (183%; Po0.001). At a lower dose (0.01 nM), SEC also increased glycerol release over the 24 h sampling period (Figure 3a) . As a positive control, treatment with isoproterenol at 10 mM significantly stimulated the release of glycerol over the same time period. Furthermore, the ex-vivo stimulation of epididymal fat depots from rats on regular chow or high-fat diet with 0.1 nM SEC significantly increased glycerol release at 3 h on high-fat diet (200 ± 45.8% vs control; Po0.005) and at 24 h on both diets (162±18.0%; Po0.05 and 263±71%; Po0.001 respectively, vs control Figure 3b ).
While glycerol is not reutilized by the adipocyte, NEFA can be reesterified and the net NEFA accumulation represents a balance between lipolysis and esterification where an increased accumulation of NEFA indicates lipolysis 4 re-esterification, while the converse is true. Altogether, the balance of these reactions represents substrate cycling. NEFA accumulation was assessed in both adipocytes (Figure 3c ) and adipose tissue (Figure 3d) . Although NEFA accumulation decreased in adipocytes (indicating increased re-esterification relative to lipolysis, Figure 3c ), NEFA accumulation increased in rat adipose tissue explants (epididymal fat depots) from rats on control chow and high-fat diet (Figure 2d ). mRNA expression and adipokine secretion. The effect of SEC on mRNA expression and adipokine secretion in mature adipocytes was also evaluated. Following 24 h treatment (0.1 nM), SEC induced a significant increase in the expression of differentiation-related transcription factors PPARg2 (206±18%; Po0.01) and C/EBPb (180 ± 8%; Po0.001), lipid uptake and storage genes FABP4 (164 ± 5%; Po0.001), DGAT-1 (144 ± 6%; Po0.05), CD36 (149±6%; Po0.05) and Cav3 (164±17%; Po0.001), insulin function related genes Glut4 243 ± 69%; Po0.05) and IRS-1 (478 ± 102%; Po0.01) as well as adiponectin (138 ± 3%; Po0.001) as presented in Figure 4a . Following the observation of the effect of SEC on the adiponectin expression, the secretion of adipokines including adiponectin, acylation-stimulating protein, C3, MCP-1 and keratinocyte-derived chemokine was evaluated in 3T3-L1 adipocytes. SEC induced a dose-dependent increase in adiponectin and MCP-1 secretion (Figure 4b ). However, SEC had Table 1 . Results are presented as average ± s.e.m. Significant differences were analyzed by analysis of variance or t-test where *Po0.05, **Po0.01 and ***Po0.001. no effect on acylation-stimulating protein, C3 and keratinocytederived chemokine secretion (Supplementary Table 2 ).
SEC receptor expression and mechanism of action in adipocytes: As presented in Figure 5a , SCTR expression was significantly modulated throughout the process of differentiation in 3T3-L1 cells. During preadipocyte differentiation, although SCTR expression was unchanged at day 3, on days 6 and 9, SCTR mRNA had increased by 17 fold Po0.001 and 11 fold, Po0.001 vs day 0, respectively. In addition, SCTR expression was evaluated in primary adipocytes derived from different fat depots. As presented in Figure 5b rat SCTR expression levels were twofold higher in retroperitoneal vs epididymal fat depots (Po0.05), while in mouse tissues, inguinal expression was greater than the epididymal depot.
Several strategies were used to evaluate the mechanism of SEC action. Treatment with a SEC (S5-27) fragment has been shown previously to interfere with SEC bioactivity. [43] [44] [45] As shown in Figure 5c , the S5-27 fragment did not influence basal FA uptake, whereas native SEC and insulin both stimulated (166 ± 6% and 238 ± 11% vs control, respectively; Po0.01-0.001). However, pretreatment of adipocytes with S5-27 completely blocked the SEC effect on FA uptake (Po0.01).
Caveolae, a subset of membrane microdomains, are particularly abundant in adipocytes and influence insulin signaling with respect to FA transport in 3T3-L1. 46 As shown in Figure 5c , b-cyclodextrin significantly reduced SEC-induced FA uptake, Po0.05. SEC also significantly increased (140.9 ± 8.7% vs control; Po0.05) intracellular cAMP (Figure 5d ) and this effect was completely blocked by pretreatment with S5-27(Po0.001).
In humans, there is no significant difference in SCTR expression in subcutaneous and omental adipose tissue (3.35 ± 0.66% vs 2.65±0.54%, respectively; P ¼ NS). As presented in Figure 6 , SCTR expression was positively correlated with body mass index (r ¼ 0.57; Po0.05), insulin levels (r ¼ 0.62; Po0.05) and apoB (r ¼ 0.67; Po0.01) in omental but not in subcutaneous (data not shown) adipose tissue. We have recently published that peptides of the ghrelin family as well as motilin influence pre-, differentiating as well as mature adipocyte functions. Interestingly, the expression of SCTR significantly correlated with mRNA levels of ghrelin receptor (GHS-R1: r ¼ 0.87; Po0.001) and FA transporter (FABP7: r ¼ 0.74; Po0.01) and glucose transporters (GLUT2: r ¼ 0.72; Po0.01 and GLUT4: r ¼ 0.84; Po0.001) as well as transcription factor (PGC-1: r ¼ 0.68; Po0.01) in omental adipose tissue derived from humans. Similarly, in human subcutaneous adipose tissue, SCTR expression was also significantly correlated with the expression of GHS-R1 (r ¼ 0.80; P ¼ 0.001), motilin receptor (MOTR: r ¼ 0.82; Po0.01), diacylglycerol acyltransferase 1 (DGAT-1: r ¼ À 0.58; Po0.05), insulin receptor substrate 1 (IRS-1: r ¼ 0.65; P ¼ 0.05) and peroxisome proliferative activated receptor g (PPARg: À 0.59; Po0.05).
DISCUSSION
The discovery of ghrelin and its adipogenic effects has created an interest in evaluating the potential effects of other GI peptides on adipocyte functions. 47 Furthermore, we have recently reported the insulin-like effect of another GI peptide, motilin, on 3T3-L1 adipocytes. Although discovered by Bayliss and Starling in 1902, we, and others, have recently highlighted the significance of revisiting the metabolic effects of SEC. Although the insulinotropic effects of SEC and its influence on glucose excursion have been evaluated in the 70's 48 there is presently little information regarding the hormone 0 s potential effects on adipose tissue. 49 However, it has been reported that SEC is preferentially released from the duodenum in response to fat or protein dietary intakes. 50, 51 In addition, the expression of the SCTR in human adipose tissue is suggestive of a potential role of SEC in adipocyte function. 49 Taken together, these elements define the relevance of evaluating SEC on preadipocyte, differentiating adipocyte and mature adipocyte functions. The most significant results of the present study are that SEC stimulates proliferation, differentiation and FA uptake while at the same time increasing NEFA and glycerol release in adipocytes, thereby enhancing substrate cycling.
Two critical functions of preadipocytes include cell proliferation and cellular differentiation. SEC stimulates both in preadipocytes. With respect to the former, SEC increased proliferation, mitochondrial activity and C/EBPb expression. This proliferative effect is consistent with the known effects of SEC on proliferation of normal cholangiocytes and gastric cells 52, 53 and stimulation of mitochondrial activity in dog acinar cells. 54 The potential involvement of the C/EBPb transcription factor in the regulation of key biological processes such as cell proliferation has been previously reported in gastric cells. 55, 56 Taken together, these results suggest that SEC promotes proliferation of 3T3-L1 preadipocytes through mitotic clonal expansion, a first step during the differentiation process. Further, long-term incubation with SEC also enhanced lipid storage over and above the standard differentiation protocol, as indicated by increases in TG storage mass. The short-term effects on proliferation and long-term effects on lipid storage point overall to a potential for SEC involvement in adipocyte differentiation.
SEC simultaneously increased FA and glucose uptake, yet at the same time increased the opposite reaction of lipolysis as evidenced by increased glycerol and NEFA release. Further SEC also increased expression of key factors, including transcription factors and lipid modulatory genes (Glut4, IRS-1, PPARg, C/EBPb, FABP4, CD36, Cav3 and DGAT-1) while stimulating both mRNA and secretion of adiponectin, as well as MCP-1 secretion. In mature adipocytes, it may be that SEC enhances the re-cycling of FAs, in a similar manner to the effect of leptin on fat cells, as discussed below. 57, 58 Interestingly, SEC increased cAMP (which leads to activation of hormone sensitive lipase). SEC was previously shown to increase cAMP intracellular levels in PC12 cells, 59 but not in isolated hepatocytes. The evidence suggesting the involvement of a common pathway responsible for both the lipogenic and lipolytic effects is supported by the inhibitory effect of the SEC peptide S5-27, which blocked both FA uptake and cAMP release. Further, an increase in intracellular cAMP level is suggested to have a critical role during the early stages of adipocyte differentiation, potentially through the increase of PPARg transcriptional activity. 60 Expression of SCTR was evaluated throughout the process of preadipocyte differentiation, with marked increases in the later stages of differentiation. Although the physiological relevance of SCTR in adipocytes has never been investigated, a previous study reports the increased expression of the receptor in omental adipose tissue of obese individuals. However, the absence of differences in body weight in wild-type vs SCTR-null mice 61 suggests that the inactivation of SCTR might not impair basal adipose tissue accumulation, but could alter adipocyte function as SCTR-null mice display higher glycemia than their wild-type littermates. On the other hand, the potential effect of SEC through the activation of another type of receptor cannot be excluded.
In humans the expression of SCTR in omental adipose tissue is positively associated with body mass index, insulin and apolipoprotein B values. Interestingly, SCTR expression was also significantly correlated to mRNA levels of GHS-R1 and MOTR as well as FA and glucose transport, TG synthesis, insulin signaling and mediators of adipocyte differentiation and function in human omental and/or subcutaneous adipose tissue.
The present results provide evidence that adipocytes are a SEC target tissue and that the response is mediated, at least in part, via an increase in intracellular cAMP levels in 3T3-L1 adipocytes. However, it should be noted that plasma circulating levels of SEC vary widely between humans, rats and mice (as mentioned above); thus, the SEC concentrations used in these experimental models range from normal physiological to supra-physiological to pharmacological (depending on the species). Although the extent of these observations will have to be validated in vivo, using species-specific physiological levels, the data collected in 3T3-L1, primary adipocytes and adipose tissue models are in line with the hypothesis suggesting that SEC could be a modulator in the regulation of esterification and hydrolysis in lipid metabolism. Simultaneous lipolysis and re-esterification form the glycerolipid/ free FA cycle, a 'futile' cycle commonly used for thermogenesis. This substrate cycling is under stringent control, and its metabolic intermediates provide important cellular signaling for many biological processes, such as energy homeostasis, insulin secretion, appetite control, aging and longevity, as reviewed recently by Prentki and Madiraju. 62 In this review, evidence is presented that alterations in the glycerolipid/free FA cycling are involved in the pathogenesis of obesity, type 2 diabetes and cancer, and may be considered as attractive therapeutic targets. 62 These elements not only confirm SCTR expression and SEC function in human adipocytes but also suggest the relevance of further evaluating the influence of SEC and other GI peptides on adipocyte functions.
